Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Håkan Ahlman

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Annals of the New York Academy of Sciences|November 15, 2006
Malignant pheochromocytoma: state of the field with future projectionsHåkan Ahlman
Neuroendocrinology|November 14, 2012
ForewordHåkan Ahlman, Bertram Wiedenmann
Expert Opinion on Investigational Drugs|April 2, 2009
Treatment of gastrointestinal stromal tumours: imatinib, sunitinib -- and then?Bengt Nilsson, Ola Nilsson, Håkan Ahlman
Pharmacology & Toxicology|June 22, 2002
Treatment of distal colitis with local anaesthetic agentsStellan Björck, Annica Dahlström, Håkan Ahlman
Lakartidningen|April 23, 2003
[Adrenalectomy in Cushing syndrome--24 cases without fatal outcome]Svante Jansson, Håkan Ahlman, Bo Wängberg
Lakartidningen|February 26, 2010
[Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear]Håkan Ahlman, Ola Nilsson, Bengt Nilsson
Neuroendocrinology|May 11, 2012
Radionuclide therapy via SSTR: future aspects from experimental animal studiesEva Forssell-Aronsson, Johan Spetz, Håkan Ahlman
Medical Physics|January 10, 2004
Model of metastatic growth valuable for radionuclide therapyPeter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Endocrine Pathology|August 8, 2002
N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinomaAmir Khorram-Manesh, Håkan Ahlman, Svante Jansson, et al.
Cancer Research|April 19, 2007
Specific growth rate versus doubling time for quantitative characterization of tumor growth rateEsmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Annals of the New York Academy of Sciences|November 15, 2006
Malignant pheochromocytoma: state of the field with future projectionsHåkan Ahlman
Neuroendocrinology|November 14, 2012
ForewordHåkan Ahlman, Bertram Wiedenmann
Expert Opinion on Investigational Drugs|April 2, 2009
Treatment of gastrointestinal stromal tumours: imatinib, sunitinib -- and then?Bengt Nilsson, Ola Nilsson, Håkan Ahlman
Pharmacology & Toxicology|June 22, 2002
Treatment of distal colitis with local anaesthetic agentsStellan Björck, Annica Dahlström, Håkan Ahlman
Lakartidningen|April 23, 2003
[Adrenalectomy in Cushing syndrome--24 cases without fatal outcome]Svante Jansson, Håkan Ahlman, Bo Wängberg
Lakartidningen|February 26, 2010
[Resistance against tyrosine kinase inhibitors in the treatment of GIST. New therapeutic possibilities appear]Håkan Ahlman, Ola Nilsson, Bengt Nilsson
Neuroendocrinology|May 11, 2012
Radionuclide therapy via SSTR: future aspects from experimental animal studiesEva Forssell-Aronsson, Johan Spetz, Håkan Ahlman
Medical Physics|January 10, 2004
Model of metastatic growth valuable for radionuclide therapyPeter Bernhardt, Håkan Ahlman, Eva Forssell-Aronsson
Endocrine Pathology|August 8, 2002
N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinomaAmir Khorram-Manesh, Håkan Ahlman, Svante Jansson, et al.
Cancer Research|April 19, 2007
Specific growth rate versus doubling time for quantitative characterization of tumor growth rateEsmaeil Mehrara, Eva Forssell-Aronsson, Håkan Ahlman, et al.
Pageof 6